Risk of reverse seroconversion of hepatitis B virus surface antigen in rituximab-treated non-Hodgkin lymphoma patients: A large cohort retrospective study
- Liang Tsai Hsiao
- , Tzeon Jye Chiou
- , Jyh Pyng Gau
- , Ching Fen Yang
- , Yuan Bin Yu
- , Chun Yu Liu
- , Jin Hwang Liu
- , Po Min Chen
- , Cheng Hwai Tzeng
- , Yu Jiun Chan
- , Muh Hwa Yang
- , Yi Hsiang Huang
- , Chun Xia Cao
Research output: Contribution to journal › Article › peer-review
15
Link opens in a new tab
Citations
(Scopus)